Description
Generic Version of Enzalutamide Available in India?
Enzalutamide is the generic name of the medication and is its international nonproprietary name. Enzalutamide is marketed under the brand name Glenza among others. Enzalutamide tablets are androgen receptor inhibitors indicated for the treatment of patients with castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
Enzalutamide was first described in 2006, and was introduced for the treatment of prostate cancer in 2012. It was the first second-generation NSAA to be introduced. It is on the World Health Organization’s List of Essential Medicines.
Who is the CFA, distributor, and retailer for Glenza (Enzalutamide) Capsules in India?
Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Glenza (Enzalutamide) Capsules in India. It is marketed by Glenmark. Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Glenmark products, including advanced cancer treatments.
The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup.
How much do Glenza Capsules cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
NEWS / UPDATES
- Recommendations of the SEC (Oncology & Haematology) made in its 147 the meeting held on 27.04.2023 at CDSCO (HQ), New Delhi:
- Zydus gets USFDA approval to produce its generic prostate cancer drug
- Beta Drugs Limited receives DCGI nod to launch Enzalutamide 160mg for treatment ..
- Zydus receives tentative approval from USFDA for Enzalutamide Tablets, 40 mg and 80 m
- FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
12 November 2025 AM (IST)
